Communication

Asymmetric Diels-Alder Reaction of 2-Arylidene-1,3-indanediones with 2-Vinylindoles Catalyzed by a Sc(OTf)3/Bis(oxazoline) Complex:Enantioselective Synthesis of Tetrahydrocarbazole Spiro Indanedione Derivatives

  • Tan Fen ,
  • Chen Jiarong ,
  • Wang Ping ,
  • Xiao Wenjing
Expand
  • a Key Laboratory of Pesticide & Chemical Biology Ministry of Education and College of Chemistry, Central China Normal University, Wuhan, 430079;
    b College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065

Received date: 2014-04-01

  Online published: 2014-05-07

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21072069, 21002036, 21232003, and 21202053) and the National Basic Research Program of China (973 program, 2011CB808600).

Abstract

Spirocyclic scaffolds are prevalent in numerous naturally occurring products and pharmaceuticals, which exhibit important biological and pharmacological activities. In this communication, a Sc(OTf)3/Bis(oxazoline) complex catalyzed asymmetric Diels-Alder reaction of 2-arylidene-1,3-indanediones with 2-vinylindoles has been developed. The reaction provides a convenient and practical approach to biologically useful and synthetically important spiro-tetrahydrocarbazoles in good yields with high enantioselectivities (16 examples, up to 92% yield, 94% ee). A representative procedure for this asymmetric Diels-Alder reaction is described below: Sc(OTf)3 (0.02 mmol) and chiral tridentate diphenyl-pybox ligand IV (0.02 mmol) were dissolved in toluene (1.5 mL) and stirred for 30 minutes at room temperature. 2-Arylidene-1,3-indanediones (0.20 mmol) was added to the above-mentioned solution and stirred at 5 ℃ for another 30 minutes. The solution of 2-vinylindoles (0.20 mmol) in toluene (0.5 mL) was then added to the reaction system and the mixture was stirred until the complete consumption of substrates (as monitored by TLC). The reaction mixture was purified directly by flash column chromatography on silica gel (petroleum ether/ethyl acetate=15:1~10:1) to give the corresponding products.

Cite this article

Tan Fen , Chen Jiarong , Wang Ping , Xiao Wenjing . Asymmetric Diels-Alder Reaction of 2-Arylidene-1,3-indanediones with 2-Vinylindoles Catalyzed by a Sc(OTf)3/Bis(oxazoline) Complex:Enantioselective Synthesis of Tetrahydrocarbazole Spiro Indanedione Derivatives[J]. Acta Chimica Sinica, 2014 , 72(7) : 836 -840 . DOI: 10.6023/A14040237

References

[1] For recent reviews, see: (a) Clive, D. L. J.; Yu, M.; Wang, J.; Yeh, V. S. C.; Kang, S. Chem. Rev. 2005, 105, 4483.
(b) Galliford, C. V.; Scheidt, K. A. Angew. Chem. Int. Ed. 2007, 46, 8748.
(c) Millemaggi, A.; Taylor, R. J. K. Eur. J. Org. Chem. 2010, 4527.
(d) Yu, J.; Shi, F.; Gong, L.-Z. Acc. Chem. Res. 2011, 44, 1156.
(e) Rios, R. Chem. Soc. Rev. 2012, 41, 1060.
(f) Franz, A. K.; Hanhan, N. V.; Ball-Jones, N. R. ACS Catal. 2013, 3, 540.
[2] For selected recent examples, see: (a) Yip, K.-T.; Zhu, N.-Y.; Yang, D. Org. Lett. 2009, 11, 1911.
(b) Girgis, A. S. Eur. J. Med. Chem. 2009, 44, 91.
(c) Sirasani, G.; Andrade, R. B. Org. Lett. 2009, 11, 2085.
(d) Cheng, L.; Liu, L.; Jia, H.; Wang, D.; Chen, Y.-J. J. Org. Chem. 2009, 74, 4650.
(e) Li, B.; Zhou, R.; He, G.; Guo, L.; Huang, W. Acta Chim. Sinica 2013, 71, 1396. (李博, 周锐, 何谷, 郭丽, 黄维, 化学学报, 2013, 71, 1396.) For chapters and selected reviews, see:
(f) Indoles, Ed.: Sundberg, R. J., Academic Press, San Diego, CA, 1996.
(g) Kleeman, A.; Engel, J.; Kutscher, B.; Reichert, D. Pharmaceutical Substances, 4th ed., Thieme, New York, 2001.
(h) Dewick, P. M. Medicinal Natural Products: A Biosynthetic Approach, 2nd ed., Wiley, New York, 2002.
(i) Fattorusso, E.; Scafati, O. T. Modern Alkaloids, WILEY-VCH, Weinheim, 2008.
(j) Knölker, H. J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303.
(k) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873.
[3] (a) Wang, Y.; Ding, K. Chin. J. Org. Chem. 2001, 21, 763. (王以, 丁奎岭, 有机化学, 2001, 21, 763. )
(b) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285.
(c) Sheng, Y.-F.; Zhang, A.-J.; Zheng, X.-J.; You, S.-L. Chin. J. Org. Chem. 2008, 28, 605. (盛益飞, 张安将, 郑晓建, 游书力, 有机化学, 2008, 28, 605.)
(d) Bandini, M.; Eichholzer, A. Angew. Chem. Int. Ed. 2009, 48, 9608.
[4] Selected recent examples for the asymmetric synthesis of tetrahydrocarbazoles, see: (a) Gioia, C.; Hauville, A.; Bernardi, L.; Fini, F.; Ricci, A. Angew. Chem. Int. Ed. 2008, 47, 9236.
(b) Jones, S. B.; Simmons, B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2009, 131, 13606.
(c) Bandini, M.; Eichholzer, A.; Gualandi, A.; Quinto, T.; Savoia, D. ChemCatChem 2010, 2, 661.
(d) Tan, B.; Hernández-Torres, G.; Barbas Ⅲ, C. F. J. Am. Chem. Soc. 2011, 133, 12354.
(e) Müller, S.; Webber, M. J.; List, B. J. Am. Chem. Soc. 2011, 133, 18534.
(f) Liu, Y.; Nappi, M.; Arceo, E.; Vera, S.; Melchiorre, P. J. Am. Chem. Soc. 2011, 133, 15212.
(g) Cai, Q.; Zheng, C.; Zhang, J.-W.; You, S.-L. Angew. Chem. Int. Ed. 2011, 50, 8665.
(h) Cai, Q.; You, S.-L. Org. Lett. 2012, 14, 3040.
(i) Wu, Q.-F.; Zheng, C.; You, S.-L. Angew. Chem. Int. Ed. 2012, 51, 1680.
(j) Liu, Y.; Nappi, M.; Escudero-Adán, E. C.; Melchiorre, P. Org. Lett. 2012, 14, 1310.
(k) Xiao, Y.-C.; Zhou, Q.-Q.; Dong, L.; Liu, T.-Y.; Chen, Y.-C. Org. Lett. 2012, 14, 5940.
(l) Bandini, M.; Bottoni, A.; Chiarucci, M.; Cera, G.; Miscione, G. P. J. Am. Chem. Soc. 2012, 134, 20690.
[5] Murdock, K. C. J. Org. Chem. 1959, 24, 845.
[6] (a) Khordorkovsky, V.; Mazor, R. A.; Ellern, A. Acta Crystallogr. 1996, C52, 2878.
(b) Schwartz, H.; Mazor, R.; Khordorkovsky, V.; Shapiro, L.; Klug, J. T.; Kovalev, E.; Meshulum, G.; Berkovic, G.; Kotler, Z.; Efrima, S. J. Phys. Chem. 2001, 105, 5914.
[7] Nishiyama, T.; Shiotsu, S.; Tsujita, H. Polym. Degrad. Stab. 2002, 76, 435.
[8] (a) Nugiel, D.; Etzkorn, A.; Vidwans, A.; Benfield, P.; Bosclair, M.; Burton, C.; Cox, S.; Czerniak, M.; Doleniak, D.; Seitz, S. J. Med. Chem. 2001, 44, 1334.
(b) Nugiel, D.; Vidwans, A.; Etzkorn, A.; Rossi, K.; Benfield, P.; Burton, C.; Cox, S.; Czerniak, M.; Doleniak, D.; Seitz, S. J. Med. Chem. 2002, 45, 5224.
[9] For preparation of 2-arylidene-1,3-indanediones, please see: (a) Inayama, S.; Mamoto, K.; Shibata, T.; Hirose, T. J. Med. Chem. 1976, 19, 433.
(b) Wu, D. Y.; Ren, Z. J.; Cao, W. G.; Tong, W. Q. Synth. Commun. 2005, 35, 3157.
(c) Sarvesh, P. K.; Nizamuddin, K. Arch. Pharm. Chem. Life Sci. 2008, 341, 418.
[10] For the asymmetric epoxidation, see: (a) Russo, A.; Lattanzi, A. Org. Biomol. Chem. 2010, 8, 2633. For the asymmetric cyclopropanation, see:
(b) Russo, A.; Meninno, S.; Tedesco, C.; Lattanzi, A. Eur. J. Org. Chem. 2011, 5096.
[11] Hua, F.-L.; Wei, Y.; Shi, M. Tetrahedron 2012, 68, 7911.
[12] (a) Ramachary, D. B.; Anebouselvy, K.; Chowdari, N. S.; Barbas Ⅲ, C. F. J. Org. Chem. 2004, 69, 5838. For an asymmetric [2+2+2] annulation, see:
(b) Kuan, H.-H.; Chien, C.-H.; Chen, K. Org. Lett. 2013, 15, 2880. For a non-asymmetric [4+2] cycloaddition, see:
(c) Li, E.-Q.; Huang, Y.; Liang, L.; Xie, P.-Z. Org. Lett. 2013, 15, 3138.
[13] (a) Lu, H.-H.; Liu, H.; Wu, W.; Wang, X.-F.; Lu, L.-Q.; Xiao, W.-J. Chem. Eur. J. 2009, 15, 2742.
(b) Wang, X.-F.; Hua, Q.-L.; Cheng, Y.; An, X.-L.; Yang, Q.-Q.; Chen, J.-R.; Xiao, W.-J. Angew. Chem. Int. Ed. 2010, 49, 8379.
(c) Wang, X.-F.; Cao, Y.-J.; Cheng, H.-G.; Chen, J.-R.; Xiao, W.-J. Org. Lett. 2010, 12, 1140.
(d) Zhu, X.-Y.; An, X.-L.; Li, C.-F.; Zhang, F.-G.; Hua, Q.-L.; Chen, J.-R.; Xiao, W.-J. ChemCatChem 2011, 3, 679.
(e) Cao, Y.-J.; Cheng, H.-G.; Lu, L.-Q.; Zhang, J.-J.; Cheng, Y.; Chen, J.-R.; Xiao, W.-J. Adv. Synth. Catal. 2011, 353, 617.
(f) Tan, F.; Xiao, C.; Cheng, H.-G.; Wu, W.; Ding, K.-R.; Xiao, W.-J. Chem. Asian J. 2012, 7, 493.
(g) Tan, F.; Cheng, H.-G.; Feng, B.; Zou, Y.-Q.; Duan, S.-W.; Chen, J.-R.; Xiao, W.-J. Eur. J. Org. Chem. 2013, 2071.
(h) Cheng, H.-G.; Lu, L.-Q.; Wang, T.; Yang, Q.-Q.; Liu, X.-P.; Li, Y.; Deng, Q.-H.; Chen, J.-R.; Xiao, W.-J. Angew. Chem. Int. Ed. 2013, 52, 3250.
(i) Tan, F.; Lu, L.-Q.; Yang, Q.-Q.; Guo, W.; Bian, Q.; Chen, J.-R.; Xiao, W.-J. Chem. Eur. J. 2014, 20, 3415.
[14] Cheng, H.-G.; Lu, L.-Q.; Wang, T.; Chen, J.-R.; Xiao, W.-J. Chem. Commun. 2012, 48, 5596.
[15]For selected reviews on the applications of chiral bis(oxazoline) ligands in asymmetric catalysis, see: (a) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.
(b) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2006, 106, 3561.
(c) Hargaden, G. C.; Guiry, P. J. Chem. Rev. 2009, 109, 2505.
(d) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2011, 111, PR284.
Outlines

/